Psyence Biomedical Ltd. Company Profile
NASDAQ: PBMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 3:59 PM ET · Delayed 15 min
Psyence Biomedical at a glance
Psyence Biomedical Ltd. (NASDAQ: PBM) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Toronto, ON, Canada. Psyence Biomedical is led by Mr. Jody Aufrichtig and employs about 12 people. At a market capitalization of $18.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001985062, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Psyence Biomedical do?
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Business description based on the company's public filings.
Company information
- Legal name
- Psyence Biomedical Ltd.
- Ticker
- NASDAQ: PBM
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Jody Aufrichtig
- Employees
- 12
- Headquarters
- 121 Richmond Street West, Toronto, ON, Canada
- Phone
- 416-477-1708
- Website
- psyencebiomed.com
- Market cap
- $18.61M
- SEC CIK
- 0001985062
Companies similar to Psyence Biomedical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares | 2.94 | -5.47% | $18.90M | vs PBM |
| NEUPNeuphoria Therapeutics Inc. | 3.36 | +0.30% | $18.18M | vs PBM |
| AKTXAkari Therapeutics plc ADS | 8.77 | +3.30% | $20.04M | vs PBM |
| NCELNewcelX Ltd. | 2.96 | -4.82% | $17.10M | vs PBM |
| COCPCocrystal Pharma Inc. | 1.07 | 0.00% | $20.61M | vs PBM |
| RADXRadiopharm Theranostics Limited ADR | 1.13 | +1.79% | $16.49M | vs PBM |
| UPCUniverse Pharmaceuticals Inc. Class A | 4.15 | 0.00% | $20.85M | vs PBM |
| MRKRMarker Therapeutics Inc. | 0.9716 | +2.27% | $16.20M | vs PBM |